Dermarium, a home care beauty device startup, announced on November 11 that it has raised undisclosed seed funding from the Gyeonggi Center for Creative Economy & Innovation (Gyeonggi CCEI) just two months after its founding.

Established in late August 2025, the beautytech company brings hospital-level skin recovery technology into the home. Its name combines “Derma” (skin) with “Atrium” (space), reflecting its mission to create a clinical-quality skincare experience in a personal setting.

Dermarium’s technology integrates RF (radiofrequency), LED (light energy), and EMS (microcurrent) into a precision control system. The platform uses medical-grade stability protocols and detection-correction algorithms to deliver consistent, efficient energy treatment with minimal skin irritation.

The startup has filed two core patents with three more in preparation. Since launching, Dermarium has earned spots in several competitive Korean government programs—including the Youth Startup Academy, Preliminary Startup Package, and Seoul National University Campus Town—validating both its technology and market fit.

“This funding validates not just our technology, but our vision for global expansion,” said Youngri Jin, CEO of Dermarium. “We’re building precision control technology with data-driven feedback to set a new ‘K-Premium Home Care’ standard for international markets.”

With fresh capital in hand, Dermarium is shifting from technology validation to market entry. The company will target North America, Japan, and Southeast Asia while preparing for its next funding round.